Vinod K Dixit - JoVE Visualize

Showing results (21-30 of 36) with videos related to

Pageof 4

Sort By:

Carbohydrate Polymers|October 19, 2021

Rasayana properties of Ayurvedic herbs: Are polysaccharides a major contributorMayank Thakur, Alexander Weng, Hendrik Fuchs, et al.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 23, 2014

Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenarioManjita Srivastava, Arttrika Ranjan, Jitendra K Choudhary, et al.

Interdisciplinary Perspectives on Infectious Diseases|February 24, 2016

Ulcerative Colitis and Its Association with Salmonella SpeciesManish Kumar Tripathi, Chandra Bhan Pratap, Vinod K Dixit, et al.

Journal of Clinical and Experimental Hepatology|October 11, 2018

Impact of Direct Acting Antiviral Drugs in Treatment Naïve HCV Cirrhosis on Fibrosis and Severity of Liver Disease: A Real Life Experience from a Tertiary Care Center of North IndiaGaurav Garg, Vinod K Dixit, Sunit K Shukla, et al.

Journal of Clinical and Experimental Hepatology|December 3, 2015

HBsAg Level as Predictor of Liver Fibrosis in HBeAg Positive Patients With Chronic Hepatitis B Virus InfectionSundeep K Goyal, Ashok K Jain, Vinod K Dixit, et al.

Journal of Clinical and Experimental Hepatology|March 11, 2015

Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern IndiaVinod K Dixit, Jayanta K Ghosh, Sangey C Lamtha, et al.

Journal of Clinical and Experimental Hepatology|May 11, 2018

INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsAnil Arora, Shivaram P Singh, Ashish Kumar, et al.

Journal of Clinical and Experimental Hepatology|October 13, 2017

Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.

Journal of Clinical and Experimental Hepatology|December 21, 2018

INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or CorticosteroidsAnil Arora, Anil C Anand, Ashish Kumar, et al.

Journal of Clinical and Experimental Hepatology|December 3, 2015

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.

Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:

Pageof 4

Carbohydrate Polymers|October 19, 2021

Rasayana properties of Ayurvedic herbs: Are polysaccharides a major contributorMayank Thakur, Alexander Weng, Hendrik Fuchs, et al.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 23, 2014

Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenarioManjita Srivastava, Arttrika Ranjan, Jitendra K Choudhary, et al.

Interdisciplinary Perspectives on Infectious Diseases|February 24, 2016

Ulcerative Colitis and Its Association with Salmonella SpeciesManish Kumar Tripathi, Chandra Bhan Pratap, Vinod K Dixit, et al.

Journal of Clinical and Experimental Hepatology|October 11, 2018

Impact of Direct Acting Antiviral Drugs in Treatment Naïve HCV Cirrhosis on Fibrosis and Severity of Liver Disease: A Real Life Experience from a Tertiary Care Center of North IndiaGaurav Garg, Vinod K Dixit, Sunit K Shukla, et al.

Journal of Clinical and Experimental Hepatology|December 3, 2015

HBsAg Level as Predictor of Liver Fibrosis in HBeAg Positive Patients With Chronic Hepatitis B Virus InfectionSundeep K Goyal, Ashok K Jain, Vinod K Dixit, et al.

Journal of Clinical and Experimental Hepatology|March 11, 2015

Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern IndiaVinod K Dixit, Jayanta K Ghosh, Sangey C Lamtha, et al.

Journal of Clinical and Experimental Hepatology|May 11, 2018

INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsAnil Arora, Shivaram P Singh, Ashish Kumar, et al.

Journal of Clinical and Experimental Hepatology|October 13, 2017

Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.

Journal of Clinical and Experimental Hepatology|December 21, 2018

INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or CorticosteroidsAnil Arora, Anil C Anand, Ashish Kumar, et al.

Journal of Clinical and Experimental Hepatology|December 3, 2015

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.

Pageof 4